SHANGHAI KAI KAI INDUSTRY COMPANY LIMITED Shanghai Kai Kai Industry Company Limited Share Price Shanghai S.E.
Equities
900943
CNE000000P04
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.368 USD | +1.94% |
|
+0.82% | -16.17% |
| Sales 2022 | 894M 123M 10.25B | Sales 2023 | 925M 127M 10.61B | Capitalization | 2.1B 289M 24.05B |
|---|---|---|---|---|---|
| Net income 2022 | 39M 5.37M 447M | Net income 2023 | 39M 5.37M 447M | EV / Sales 2022 | 1.81 x |
| Net cash position 2022 | 261M 35.95M 3B | Net cash position 2023 | 240M 33.04M 2.75B | EV / Sales 2023 | 2.01 x |
| P/E ratio 2022 |
59.9
x | P/E ratio 2023 |
70.9
x | Employees | 492 |
| Yield 2022 |
0.52% | Yield 2023 |
0.43% | Free-Float | 68.87% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.94% | ||
| 1 week | +0.82% | ||
| Current month | -11.75% | ||
| 1 month | -13.21% | ||
| 3 months | -20.35% | ||
| 6 months | -15.01% | ||
| Current year | -16.17% |
1 week
0.35
0.37
1 month
0.320.42
Current year
0.320.49
1 year
0.320.59
3 years
0.320.82
5 years
0.320.82
10 years
0.321.96
| Managers | Title | Age | Since |
|---|---|---|---|
Guang Jing Liu
CEO | Chief Executive Officer | 46 | 05/13/05 |
Heng Chen
DFI | Director of Finance/CFO | 51 | 26/20/26 |
Wen Bo Zhou
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xiang Hua Zhang
BRD | Director/Board Member | 65 | 25/06/25 |
Hu Jun Tang
BRD | Director/Board Member | 54 | 26/15/26 |
Guang Jing Liu
CEO | Chief Executive Officer | 46 | 05/13/05 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/24/28 | 0.368 | +1.94% | 104,156 |
| 27/24/27 | 0.361 | -1.90% | 105,100 |
| 26/24/26 | 0.368 | +2.79% | 97,166 |
| 25/24/25 | 0.358 | +0.56% | 38,200 |
| 24/24/24 | 0.356 | -2.47% | 85,800 |
End-of-day quote Shanghai S.E., June 28, 2024
More quotes
Shanghai Kai Kai Industrial Co Ltd is a China-based company mainly engaged in the provision of pharmaceutical distribution and services. The Company operates primarily through three segments. The Pharmaceutical segment is mainly engaged in the wholesale and retail of Chinese and Western medicines, medical equipment and reagents and consumables, as well as the provision of health services such as medicine and health, medical health, and medical care and health. The Apparel segment is mainly engaged in the wholesale and retail of Kaikai brand shirts, sweaters and clothing series, as well as the group purchasing business of Mangenisen brand series of school uniforms. The Other segment is mainly engaged in leasing business. The Company mainly conducts its businesses in the domestic market.
Sector
Pharmaceuticals
Calendar
26/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -2.46% | 23.95B | |
| +14.23% | 8.7B | |
| +1.47% | 8.29B | |
| -32.92% | 6.7B | |
| +18.62% | 5.38B | |
| +1.10% | 4.08B | |
| -9.24% | 3.79B | |
| -10.20% | 3.3B | |
| +7.58% | 3.2B |
- Stock Market
- Equities
- 600272 Stock
- 900943 Stock
